JMJ has invested in over 300 growth companies listed on NASDAQ, OTCBB, and NYSE MKT. We have a current focus on life sciences, and we are also particularly interested in market driven opportunities in technology, energy, metals, and other natural resources.
Our typical holdings range from $100,000 to $3,000,000 or more. We typically enter transactions with additional capital reserved for follow-on investment as the company successfully achieves key milestones.
Portfolio Companies by Sector
35%
Technology
18%
Life Sciences
15%
Energy
13%
Consumer
11%
Metals / Minerals
8%
Other
Our $4.2 million investment in Northwest Biotherapeutics (NWBO) led to an uplist to NASDAQ.
The company has gone on to raise over $100 million.
Selected Investment Highlights
ACAR $1,700,000
ACTC $8,500,000
ADXS $2,400,000
ALLM $500,000
BLNK $3,500,000
BKYI $250,000
BLSP $2,000,000
CBAI $7,300,000
DUOT $2,000,000
IMUN $525,000
ITKG $1,500,000
LBSR $600,000
LEXG $675,000
MAXD $900,000
MSLP $1,400,000
NVIC $625,000
NWBO $4,200,000
PBIO $975,000
Richard Corredera, CFO
CrowdGather, Inc.
“I wanted to thank JMJ for being a valuable partner and assisting us with our capital needs. We very much appreciated their
flexibility and candor. At all times, I felt they were working to an end in which both CrowdGather and JMJ could meet their
objectives in a reasonable and responsible fashion.
I would look forward to working with JMJ again in the future.”
